Could a new nasal delivery method finally get drugs to the central nervous system?

The future status of pharma intellectual property in the UK depends on the outcome of Brexit.

Despite efforts to round up counterfeit criminals, fake medicines still find their way into supply chains.

A look a Millipore Sigma’s global network of collaboration facilities, ‘M-Lab’

Unravelling the challenges and trends in formulation best practice – and why softgels and lipids are leading the way

Serialization is far from simple, and many companies overlook key aspects

The US and and EU deadlines are approaching, but is the industry ready for serialization?

Nine years ago we set out to characterize and evaluate our raw materials - this is what we found out…

Scaling up a bioprocess doesn’t need to be a headache - especially when there are firms out there that can lend a helping hand

Today's small molecules are increasingly complex, but generic producers must keep track of trends